The role of adipokines in β-cell failure of type 2 diabetes.
Dunmore, Simon J Brown, James E. P.
Dunmore, Simon J
Brown, James E. P.
Authors
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2012-09
Submitted date
Subjects
Alternative
Abstract
β-Cell failure coupled with insulin resistance is a key factor in the development of type 2 diabetes. Changes in circulating levels of adipokines, factors released from adipose tissue, form a significant link between excessive adiposity in obesity and both aforementioned factors. In this review, we consider the published evidence for the role of individual adipokines on the function, proliferation, death and failure of β-cells, focusing on those reported to have the most significant effects (leptin, adiponectin, tumour necrosis factor α, resistin, visfatin, dipeptidyl peptidase IV and apelin). It is apparent that some adipokines have beneficial effects whereas others have detrimental properties; the overall contribution to β-cell failure of changed concentrations of adipokines in the blood of obese pre-diabetic subjects will be highly dependent on the balance between these effects and the interactions between the adipokines, which act on the β-cell via a number of intersecting intracellular signalling pathways. We emphasise the importance, and comparative dearth, of studies into the combined effects of adipokines on β-cells.
Citation
The role of adipokines in β-cell failure of type 2 diabetes. 2013, 216 (1):T37-45 J. Endocrinol.
Publisher
Research Unit
PubMed ID
22991412
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
Series/Report no.
ISSN
1479-6805